Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Iba1 ELISA Kit (AC2539)
Cat.#: ASET-1128
Specifications
Description Rat Iba1 ELISA Kit allows for the in vitro quantitative determination of rat Iba1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2340 Mouse alpha MSH ELISA Kit (AC3751) Quantitative inquiry ASET-1201 Rat MAP2 ELISA Kit (AC2612) Quantitative inquiry ASET-2302 Human KCNN4 ELISA Kit (AC3713) Quantitative inquiry ASET-1401 Rat Estrogen Receptor beta ELISA Kit (AC2812) Quantitative inquiry ASET-2244 Human Big Dynorphin ELISA Kit (AC3655) Quantitative inquiry ASET-2460 Human SHC ELISA Kit (AC3871) Quantitative inquiry ASET-1897 Mouse Estrogen Receptor beta ELISA Kit (AC3308) Quantitative inquiry ASET-2539 Human Somatostatin Receptor 5 ELISA Kit (AC3950) Quantitative inquiry ASET-1252 Human Granuphilin ELISA Kit (AC2663) Quantitative inquiry ASET-1470 Human GCH1 ELISA Kit (AC2881) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket